Per Jonasson

Title: Per Jonasson: Innovator in Insulin C-Peptide Production

Introduction

Per Jonasson is a notable inventor based in Sodermannagatan, Sweden. He has made significant contributions to the field of biotechnology, particularly in the production of insulin C-peptide. His innovative approach has the potential to enhance the efficiency of insulin production, which is crucial for diabetes management.

Latest Patents

Jonasson holds a patent for the "Recombinant expression of insulin C-peptide." This invention provides a method for producing insulin C-peptide by expressing a multimeric polypeptide in a host cell. The process involves cleaving the expressed polypeptide to release single copies of the insulin C-peptide. Additionally, the patent includes nucleic acid molecules, expression vectors, and host cells that are utilized in this method.

Career Highlights

Throughout his career, Jonasson has demonstrated a commitment to advancing medical biotechnology. His work has not only contributed to scientific knowledge but also has practical applications in the healthcare industry. He is associated with Creative Peptides Sweden AB, where he continues to innovate and develop new methods for peptide production.

Collaborations

Jonasson has collaborated with esteemed colleagues such as Stefan Stahl and Mathias Uhlen. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of biotechnology.

Conclusion

Per Jonasson is a distinguished inventor whose work in insulin C-peptide production exemplifies innovation in biotechnology. His contributions are vital for improving diabetes treatment and advancing medical science.